Pilot study to determine the extent of resection when C11-Acetate PET guided navigation surgery is performed in patients with brain tumors

Not Applicable

Recruiting

• Conditions: Neoplasms

• Registration Number: KCT0006269
• Lead Sponsor: Yonsei University Health System, Severance Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 June 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

1. Adult males and females 20 years of age or older
2. Patients with primary glioma diagnosed for the first time

Exclusion Criteria

1. Patients who received chemotherapy or radiation therapy as a pre-treatment
2. In the case of those who cannot read the consent form (eg, illiterate, foreigner, etc.)

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Analyze the resected tissue and analyze whether there is a histological difference between the core portion where MRI enhancement and acetate uptake coexist, the portion where there is no MRI enhancement enhancement, only acetate uptake, and the margin of the normal tissue side. Find the most suitable value by cutoff of Acetate PET ROI.

Secondary Outcome Measures

Name	Time	Method
Overall and Progression Free Survival of Patients Operated by Acetate PET/CT Navigation Surgery